What investor type does Boston Scientific fit best in FoxScore?

Boston Scientific fits a more opportunity-seeking investor type in FoxScore: performance is the strongest sub-score. That suggests above-average historical returns — but check stability to ensure the performance wasn’t “paid for” with high volatility or deep drawdowns.

How meaningful is the available history for Boston Scientific?

Boston Scientific currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for Boston Scientific

BSX · As of: 02/17/2026

Basic information

Type: Stock

Region: US

Sector: Health Care

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

Boston Scientific develops medical devices for minimally invasive procedures, including cardiology, rhythm management, endoscopy, and urology. Revenue comes from implants and single-use devices (for example catheters and stents) plus related equipment and services. Customers are hospitals and specialty clinics worldwide, with the US as a major market.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Boston Scientific (BSX) currently has a total score of 50 points, placing it in the neutral range. The score is made up of Performance (68), Stability (45) and Trend (11). The profile is clearly uneven: Performance stands out while Trend lags.

Performance scores 68 points (strong). Key strength: 10Y return at 372.6 %. Main drag: 1Y return at -28.5 %. This suggests stronger long-term than short-term performance.

Stability scores 45 points (neutral). Key strength: CAGR/drawdown ratio at 0.39. Weaker metric: return/volatility ratio at -1.01. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 11 points (very weak). Trend signals are mostly negative right now. Least weak metric: 12M momentum at -15.2 %. Main drag: Price is about 16.5 % below SMA50.

Overall, the picture is mixed: Performance does the heavy lifting while Trend holds the score back. On a metric level, CAGR/drawdown ratio stands out, while return/volatility ratio is the main weak spot.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

neutral

Scores

Metrics

FAQ

What investor type does Boston Scientific fit best in FoxScore?: Boston Scientific fits a more opportunity-seeking investor type in FoxScore: performance is the strongest sub-score. That suggests above-average historical returns — but check stability to ensure the performance wasn’t “paid for” with high volatility or deep drawdowns.
How meaningful is the available history for Boston Scientific?: Boston Scientific currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.